Plasma Transforming Growth Factor-β1 Level in Patients with Severe Community-acquired Pneumonia and Association with Disease Severity
- 31 January 2009
- journal article
- research article
- Published by Elsevier BV in Journal of the Formosan Medical Association
- Vol. 108 (1), 20-27
- https://doi.org/10.1016/s0929-6646(09)60028-0
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Markers of treatment failure in hospitalised community acquired pneumoniaThorax, 2008
- Predictive Value of Serial Measurements of sTREM-1 in the Treatment Response of Patients with Community-acquired PneumoniaJournal of the Formosan Medical Association, 2007
- Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediatorsEuropean Respiratory Journal, 2007
- Prognosis of community acquired pneumonia (CAP): Value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory responseCytokine, 2007
- Etiology and Cytokine Expression in Patients Requiring Mechanical Ventilation Due to Severe Community-acquired PneumoniaJournal of the Formosan Medical Association, 2006
- Value of APACHE II, SOFA and CPIS Scores in Predicting Prognosis in Patients with Ventilator-Associated PneumoniaRespiration, 2006
- Prospective evaluation of pneumonia severity index in hospitalised patients with community-acquired pneumoniaRespiratory Medicine, 2004
- Plasma Level of a Triggering Receptor Expressed on Myeloid Cells-1: Its Diagnostic Accuracy in Patients with Suspected SepsisAnnals of Internal Medicine, 2004
- Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) GroupCritical Care, 2004
- Anti-Inflammatory CytokinesChest, 2000